Search results
Sanofi (SNY) to Reduce Lantus Insulin Price by Up to 78%
Zacks via Yahoo Finance· 1 year agoSanofi SNY announced up to a 78% cut in the list price of its most popular insulin, Lantus,...
Sanofi Raises Profit Guide And Reverses A Drug-Pricing Pitfall
Investor's Business Daily· 2 years agoSanofi stock ended flat Thursday — reversing earlier declines — despite lifting its profit guidance...
Is Sanofi Stock a Buy Now?
Motley Fool· 1 year agoFrench pharmaceutical giant Sanofi (NASDAQ: SNY) has long been a leader in the market for insulin. First, Sanofi was forced to decrease the price of its...
Sanofi (SNY) Stock Moves -0.45%: What You Should Know
Zacks via Yahoo Finance· 1 year agoSanofi (SNY) closed at $55.47 in the latest trading session, marking a -0.45% move from the prior...
Sanofi Could Be on a Roll With a Strong Performance and Its Latest FDA Approval
Motley Fool· 1 year agoFrench pharmaceutical company Sanofi (NASDAQ: SNY) is seeing a jump in its share price following...
Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoSanofi SNY will report third-quarter 2022 results on Oct 28 before market open. In the last reported...
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Motley Fool· 1 year agoRecently, Sanofi (NASDAQ: SNY) and Regeneron (NASDAQ: REGN) received positive news from the U.S....
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool· 2 years agoOn May 20, the U.S. Food and Drug Administration (FDA) approved Sanofi (NASDAQ: SNY) and Regeneron's...
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoSanofi-Regeneron stocks are trading higher today after their blockbuster drug aced the pivotal COPD...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
